Ancillary Studies
Medical science has advanced greatly since ARIC began in 1987, and we have remained both a cornerstone of cardiovascular research and a bridge to other areas of clinical study.
Additional research questions have been asked that have led to new studies and investigations using ARIC data and/or added voluntary involvement by our participants.
Almost 300 ancillary studies have been funded to date and these studies are continuing to provide valuable information and answer important questions. Since ARIC began in 1987, the study has contributed to the foundation of cardiovascular disease epidemiology and the decades of high quality data provide a bridge to other areas of clinical study. Some recent examples include studying genetic markers associated with heart failure to help identify possible targets for new medicines, trying to understand why individuals with cancer appear to age faster, and the relationships between the microbes in our gut and problems with our memory and thinking as we age.
Ancillary Study Policies
The following are intended to assist researchers developing proposals for Ancillary Studies. For more information on obtaining access to ARIC data, please visit our Obtain/Submit Data page.
Ancillary Study Proposals must be submitted EIGHT WEEKS prior to the grant submission date.
Title | Date Sort ascending | View |
---|---|---|
Ancillary Studies Policy | 08/12/2024 | |
Ancillary Studies Review Protocol | 07/26/2024 | |
ARIC Biospecimen Approval and Distribution Policy | 06/14/2023 | |
Ancillary Studies Proposal Form | 04/04/2023 | DOCX |
Ancillary Studies Reviewer List | 10/19/2022 | |
Ancillary Studies Review Form | 10/19/2022 | |
ARIC Ancillary Study Data and Tracking | 09/17/2020 | |
ARIC Data Sharing Policy on Geocode Data | 08/07/2020 | |
Third Party Agreement Guidelines | 03/19/2020 | |
ARIC Ancillary Study Review Policy | 12/20/2018 |